Most Recent Report “Manufacturing of Vaccines” Published by MarketPublishers.com

09 Sep 2011 • by Natalie Aster
Most Recent Report “Manufacturing of Vaccines” Published by MarketPublishers.com

LONDON – According to estimates, Singapore and China, along with the leader in the global vaccine industry – India, are emerging as the largest hot regions for the future of vaccine manufacturing. The vaccine manufacturing sector of Singapore is growing at a rate of around 20%. Furthermore, these three aforementioned countries get a high level of regulatory support from the governments.

New research report “Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing” elaborated by GBI Research presents valuable insights into the production methods of vaccines and into vaccine production capacity. It details the egg-based and cell culture-based vaccine manufacturing processes as well as the overall process throughput and the technologies used in vaccine manufacturing. A clear picture of the regulatory landscapes of the US, Europe and Japan is also provided. Furthermore, the study examines the emerging technologies, drivers and barriers of the vaccine manufacturing process along with the challenges and unfilled needs existing in the marketplace.

Report Details:

Title: Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing
Published: September, 2011
Pages: 79
Price: US$ 3,500.00

Contents:

1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures

2 MANUFACTURING OF VACCINES - INTRODUCTION
2.1 GBI Research Report Guidance

3 MANUFACTURING OF VACCINES - OVERVIEW OF MANUFACTURING
3.1 Upstream Bioprocessing
3.2 Downstream Bioprocessing
3.3 Methods for Producing Vaccines
  3.3.1 Live Whole Virus Vaccines
  3.3.2 Inactivated Whole Virus Vaccines
  3.3.3 Subunit Vaccines
  3.3.4 Recombinant Virus Vaccines
  3.3.5 Egg-Based Vaccines
  3.3.6 DNA Vaccines
3.4 Current Scenario of the Vaccine Manufacturing Industry

4 MANUFACTURING OF VACCINES - ROLE OF MANUFACTURING IN THE VACCINE INDUSTRY
4.1 Comparison of Manufacturing of Vaccines with Manufacturing of Biologics
4.2 Stakeholders for Manufacturing within the Company
  4.2.1 R&D Division
  4.2.2 Marketing Division
  4.2.3 Sales Division
  4.2.4 Manufacturing Division
4.3 Stakeholders for Manufacturing within the Industry
  4.3.1 Raw Material Suppliers
  4.3.2 Packaging Suppliers
  4.3.3 Distributors

5 MANUFACTURING OF VACCINES - VACCINE MANUFACTURING PROCESS
5.1 Overview
  5.1.1 Inactivated Influenza Vaccines
  5.1.2 Live Attenuated Influenza Vaccines
  5.1.3 Pandemic Influenza Vaccines
5.2 Raw Materials
  5.2.1 Process Design
  5.2.2 Key Positions
  5.2.3 Supporting Technology

To order the report or ask for free sample pages, please contact ps@marketpublishers.com

 

CONTACTS

The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970

ps@marketpublishers.com

www.marketpublishers.com